larsucosterol

N/A

Report date: 2026/03/20 20:03:07
NME

Base Information

Drug Namelarsucosterol
Drug Alias NameDUR-928DV-928
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInflammation mediators inhibitorsLipid modulators
TargetsInflammation mediatorsLipid
Therapy Area/IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Hepatitis, Alcoholic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesAustralia +[6] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesVirginia Commonwealth University
China Registration ClassN/A

Develop Information

Active CompaniesDurectNational Institute On Alcohol Abuse And AlcoholismBausch Health Americas Inc
Inactive CompaniesN/A
Active IndicationsHepatitis, AlcoholicHepatitis
Inactive IndicationsPlaque psoriasisCoronavirus Disease 2019 (COVID-19)Cholangitis, Sclerosing

Other Information

ATC CodeN/A
Related LinksN/A